Drug Database
NE

nedocromil sodium (Rapitil / Alocril)

✓ Approved

AbbVie, Inc. · 小分子 · 小分子

什么是 nedocromil sodium?

nedocromil sodium 是一种小分子,由AbbVie, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Others、Topical。

药物档案

商品名Rapitil, Alocril
公司AbbVie, Inc.
药物类别小分子
给药途径Others, Topical
状态Approved

治疗适应症

nedocromil sodium 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsConjunctivitis✓ Approved
Skin and subcutaneous tissue disordersPruritus✓ Approved

相关研究文献

PubMedRSC advances2026-11-17

Advancement in graphene-based anode materials for high-performance sodium-ion batteries.

Worku Ababay Ketema AK, Mamba Bhekie B BB, Palaniyandy Nithyadharseni N, Makgwane Peter Ramashadi PR et al.

Sodium-ion batteries (SIBs) have emerged as an alternative for lithium-ion batteries (LIBs) in energy storage applications, because of their similar electrochemical performance, abundance of sodium resources, and low cost. However, compared to lighter and smaller Li+, the heavier mass and bigger radius of Na+ lead to lower electrochemical kinetics and larger volume expansion of active materials. Graphene-based anode materials demonstrate improved and diverse properties for SIBs in terms of high-rate capability, flexible-battery structures, high specific capacity and long cycling life due to their unique characteristics such as high theoretical capacity, high electronic conductivity, great mechanical strength, high charge carrier mobility, and large surface area. Moreover, when combined with other nanomaterials in electrodes, graphene can enhance electrical conductivity, control large volume changes, and accelerate reaction kinetics. The article addresses the latest developments in the application of graphene-based anodes for SIBs, emphasizing their characteristics, fabrication process, sodium storage technique, and electrochemical performance. In order to improve the sodium storage performance of graphene-based electrodes, challenges, and strategies for improving anode performance are also discussed.

PMID 43041803
阅读全文 →
PubMedSmall (Weinheim an der Bergstrasse, Germany)2026-11-17

Foam-Carbon Surface Reconstruction for Fast and Durable Sodium Storage in Lignite-Derived Hard Carbon.

Yuan Xinyao X, Zhuo Fan F, Gao Hong H, Xing Yuxiu Y et al.

Developing low-cost hard carbon anodes that simultaneously achieve high initial Coulombic efficiency, rapid sodium-storage kinetics, and long-term durability remains a major challenge for the practical application of sodium-ion batteries. Herein, inspired by hierarchical porous architectures, we report a starch-derived carbon foam coating strategy to reconstruct the surface of lignite-derived hard carbon. The ultrathin carbon foam layer provides interconnected Na+ transport channels, accessible storage sites, and enriched oxygen-containing surface species. Easter-associated interfacial coupling promotes carbon-layer rearrangement and closed-pore development during carbonization, thereby integrating rapid Na+ transport with enhanced sodium storage. As a result, the optimized hard carbon delivers a reversible capacity of 401.4 mAh g-1, a high initial Coulombic efficiency of 91.7%, and outstanding cycling stability, retaining 75.8% of its capacity after 15 000 cycles. Comprehensive electrochemical analyses and density functional theory calculations reveal that the reconstructed architecture lowers sodium-ion diffusion barriers and promotes synergistic adsorption, interlayer insertion, and nanopore filling. A full sodium-ion battery assembled with Na3V2(PO4)3 further demonstrates the practical feasibility of the reconstructed hard carbon anode. This work establishes foam-carbon surface reconstruction as an effective interface-engineering strategy for activating low-rank coal toward practical hard carbon anodes and provides a general pathway for sustainable carbon materials in next-generation SIBs.

PMID 43042785
阅读全文 →
PubMedJournal of medical case reports2026-11-17

From aquaresis to antidiuresis: urine output-guided management of extreme hypernatremia (> 180 mmol/L) in central diabetes insipidus with reduced intracranial compliance: a case report.

Yusof Zaki Ahmad Syahmi AS, Muhamad Nur Izat NI, Walter Sandosam Ezelea Elwina EE, Wan Mohamed Wan Mohd Izani WMI

Acute decompensation in central diabetes insipidus (CDI) is frequently misinterpreted as a disorder of serum sodium rather than real-time water balance. Reliance on sodium alone may delay recognition of ongoing aquaresis and result in inappropriate or unsafe correction strategies. In patients with intracranial pathology, reduced cerebral compliance further amplifies vulnerability to osmotic shifts, rendering both hypernatremia and its correction potentially injurious. We present a case of extreme hypernatremia developing within 24 h following desmopressin omission, highlighting urine output as the primary real-time marker of disease activity and redefining management priorities in acute CDI. A 15-year-old boy with pineal germinoma complicated by obstructive hydrocephalus and established CDI on desmopressin developed acute agitation and reduced consciousness following omission of a scheduled dose during chemotherapy. Within 24 h, serum sodium rose from 141 mmol/L to 189 mmol/L, with serum osmolality of 385 mOsm/kg. Urine osmolality remained inappropriately low (105 mOsm/kg), confirming ongoing aquaresis. Management prioritized restoration of AVP activity using intravenous desmopressin alongside hypotonic fluid replacement titrated to urine output rather than serum sodium. Following administration, urine osmolality increased to 647 mOsm/kg with abrupt reduction in urine output, representing transient desmopressin-induced antidiuresis before recurrence of dilute polyuria as pharmacological effect waned. Sodium correction was deliberately limited to < 10 mmol/L/day in view of ventricular dilatation and reduced intracranial reserve. The patient demonstrated progressive neurological recovery with stabilization of serum sodium. Subsequent evaluation revealed previously unrecognized panhypopituitarism, including central adrenal insufficiency and central hypothyroidism, necessitating sequential hormone replacement. This case demonstrates that acute CDI decompensation is fundamentally a disorder of dynamic water flux rather than isolated dysnatremia. Urine output provides the most immediate indicator of AVP activity, whereas serum sodium represents a delayed cumulative consequence. Intravenous desmopressin induces rapid shifts from uncontrolled aquaresis to transient antidiuresis, creating a narrow therapeutic window requiring careful titration. In the presence of reduced intracranial compliance, sodium correction strategies must be individualized beyond conventional time-based classifications. Structural CDI should also prompt systematic evaluation of anterior pituitary function, as global axis failure may remain clinically silent until physiological stress unmasks it. Management strategies that prioritize serum sodium over urine output risk both delayed intervention and iatrogenic overcorrection.

PMID 43040399
阅读全文 →
PubMedDermatology online journal2026-11-17

A successful combination treatment approach to nonuremic calciphylaxis with intravenous and intralesional sodium thiosulfate.

Patel Raj H RH, Patel Aditi A, Rush Patrick P, Chitnavis Padma P et al.

PMID 43040812
阅读全文 →
PubMedLangmuir : the ACS journal of surfaces and colloids2026-11-17

Chemical Regulation of Multiscale Crack Healing in Cementitious Materials by Active Components of Crystalline Admixtures.

Wang Ruiyang R, Jia Huiting H, Zhang Junsi J, Yu Jincheng J et al.

Crystalline admixtures facilitate crack self-healing in cementitious materials via precipitation and ion migration, yet the specific chemical roles of individual active components remain poorly understood, limiting insight into the underlying healing mechanisms. To address this issue, sodium carbonate, sodium silicate, and calcium formate were selected as representative active components of crystalline admixtures and comparatively investigated through single-component analysis. The self-healing behavior of mortar was evaluated based on crack width evolution, relative water flow ratio, compressive strength retention, chloride migration coefficient, pore structure characteristics, and the structure and composition of healing products. The results indicated that all three functional admixtures promoted crack healing by inducing precipitation reactions, while exhibiting distinct roles at different scales. Sodium silicate showed the most pronounced effect on internal microcrack healing and pore structure refinement. After preloading and curing, the compressive strength retention of mortar containing sodium silicate increased to 90.4%, and the chloride migration coefficient decreased to 5.43 × 10-12 m2/s, accompanied by a noticeable reduction in large pores. In contrast, calcium formate performed better in macroscopic crack closure. Mortar incorporating calcium formate achieved complete healing of cracks with dimensions between 0.10 and 0.36 mm, while the relative water flow ratio decreased to 4.8% and the cumulative water absorption was decreased by 35.4% compared with the ordinary mortar. XRD analysis identified CaCO3 as a major crystalline phase in the crack regions. The incorporation of functional admixtures led to a more continuous and denser deposition layer, among which calcium formate formed a more intact healing layer at the crack surface, contributing to more stable crack closure.

PMID 43043054
阅读全文 →
PubMedBMC neurology2026-11-17

Comparative efficacy, safety, and dosing convenience of wake-promoting agents and sodium oxybate formulations for narcolepsy: a systematic review and network meta-analysis.

Jiang Qingqing Q, Gu Zhengtian Z

We conducted a network meta-analysis (NMA) to rank the comparative efficacy, safety, and dosing convenience of novel and traditional narcolepsy therapies. We analyzed randomized controlled trials (RCTs) comparing solriamfetol, pitolisant, stimulants, and various oxybate formulations. The literature search was updated through July 15, 2026. Primary outcomes were Epworth Sleepiness Scale (ESS) and Maintenance of Wakefulness Test (MWT) changes. Secondary outcomes included weekly cataplexy rate (WCR) and safety. Treatments were ranked using frequentist NMA P-scores. Fourteen RCTs (1,811 patients) were included. The updated search identified no new completed RCT suitable for the main NMA. Solriamfetol 300 mg yielded the greatest subjective sleepiness improvement (ESS MD -5.47; P-score 0.9692). For objective wakefulness (MWT), low-sodium oxybate (MD 11.80 min; P-score 0.9549) and solriamfetol 300 mg (P-score 0.9216) ranked highest. For cataplexy reduction, traditional sodium oxybate (SXB) 6 g (P-score 0.9978) was most efficacious. Solriamfetol 300 mg maximizes wake-promotion but increases gastrointestinal risks. ON-SXB may provide a clinically attractive balance of efficacy and dosing convenience; however, this conclusion represents an interpretive synthesis rather than a formal MCDA-derived or composite-weighted ranking outcome. PROSPERO CRD420261297749.

PMID 43040281
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多nedocromil sodium